Breaking News

Tweet TWEET

PerkinElmer Launches Automated Workstation for Improved Process Development of Protein Therapeutics

  PerkinElmer Launches Automated Workstation for Improved Process Development
  of Protein Therapeutics

Highly flexible instrument increases sample throughput enabling earlier access
                           to critical information

PepTalk Conference 2013 Booth #312

Business Wire

PALM SPRINGS, Fla. -- January 21, 2013

PerkinElmer, Inc., a global leader focused on improving the health and safety
of people and the environment announced the launch of the JANUS^® BioTx Pro^TM
automated workstation for improved process development of protein therapeutics
at the 12^th Annual Protein Science Week (PepTalk), January 21–25 in Palm
Springs, Florida at booth #312. Designed for high throughput, small scale
protein purification, it is the only workstation that accommodates multiple
chromatography modes (column, tip and batch) eliminating the need for multiple
instruments, resulting in more efficient and cost effective sample processing.

The JANUS(R) BioTx Pro(TM) automated workstation for improved process
development of protein therape ...

The JANUS(R) BioTx Pro(TM) automated workstation for improved process
development of protein therapeutics (Photo: Business Wire)

“Sample preparation for protein characterization can be a time consuming and
tedious process,” said Kevin Hrusovsky, president Life Sciences and
Technology, PerkinElmer “Automating this function frees up valuable research
time and enables scientists to obtain critical information earlier in the
protein development pipeline. This is particularly important to support
quality by design experimentation in both upstream and downstream processes to
improve product quality and reduce development time.”

The JANUS BioTx Pro enables small scale purification of µg to mg proteins on
one system instead of three individual dedicated systems, supporting the use
of commercially available plate and column based screening tools like GE
PreDictor^™ plates, PhyNexus PhyTip® columns and Atoll columns. Applications
for the workstation include resin binding studies and conditions screening.

On January 24, at 9:50am, at the PepTalk Conference, Jeremy Lambert, Portfolio
Director, Automation, will present a talk on PerkinElmer’s Automation and
microfluidics technologies including how the JANUS Biotx Pro saves researchers
time by automating sample preparation for protein characterization.

PerkinElmer has a portfolio of solutions across the biotherapeutics workflow,
from target identification, cloning and expression to safety testing and
quality control, to help ensure the consistent, reproducible results that
biotherapeutics research and patient safety considerations demand. The
portfolio includes the LabChip^® GXII^TM benchtop microfluidic system for high
throughput protein analysis and characterization, and AlphaLISA^® assays, a
no-wash ELISA alternative technology for biomarker identification, safety
testing and toxicity studies.

For more information about PerkinElmer’s biotherapeutics solutions, please
visit: http://www.perkinelmer.com/biotherapeutics

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The company reported revenue of
approximately $1.9 billion in 2011, has about 7,400 employees serving
customers in more than 150 countries, and is a component of the S&P 500 Index.
Additional information is available through 1-877-PKI-NYSE, or at
www.perkinelmer.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130121005784/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50537869&lang=en

Contact:

Edelman (On behalf of PerkinElmer, Inc.)
Paul Barren, 404-460-9679
paul.barren@edelman.com